Weight loss medications like Ozempic could become an unexpected factor in airline operating costs. As more Americans adopt these drugs, bodyweight reductions across the population could translate into measurable fuel savings for carriers. The lighter overall passenger load means less fuel consumption per flight—a ripple effect from public health trends touching the economics of aviation and energy markets.